Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04925791 · ClinicalTrials.gov registry record · NA

Does Limb Pre-Conditioning Reduce Pain After Hip Arthroscopy

A NA study, sponsored by Cedars-Sinai Medical Center.

Completed
Registry status
NA
Development phase
68
Enrollment target

NCT04925791: Completed NA study, sponsored by Cedars-Sinai Medical Center.

NCT04925791 is a NA study that has completed, run by Cedars-Sinai Medical Center. The registered enrollment target is 68 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04925791, a NA study, has completed, sponsored by Cedars-Sinai Medical Center.

COMPLETED
Registry status
NA
Development phase
68 participants
Enrollment target

Study Summary

The purpose of this study is to determine if the utilization of Ischemic Pre-Conditioning 24-hours prior to hip arthroscopy decreases patient's post-operative pain and opioid consumption.

Primary Outcome

Pain score 0-10 with 0 being no pain and 10 being the worst

Interventions

  • DIAGNOSTIC_TEST standardized pre-conditioning treatment
  • DIAGNOSTIC_TEST Partial occlusion

Trial Details

FieldValue
Enrollment Target 68 participants
Start Date 2021-10-18
Est. Completion 2023-10-20
Phase NA
Cedars-Sinai Medical Center

339 total trials

What the finished NCT04925791 record still lists

NCT04925791 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 68 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).

The record links to 0 conditions, and to 2 interventions - of which standardized pre-conditioning treatment is the first listed.

NCT04925791 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04925791 about?

NCT04925791 is a clinical study titled "Does Limb Pre-Conditioning Reduce Pain After Hip Arthroscopy". The purpose of this study is to determine if the utilization of Ischemic Pre-Conditioning 24-hours prior to hip arthroscopy decreases patient's post-operative pain and opioid consumption.

What is the current status of trial NCT04925791?

This trial is currently completed. It is a NA study. The enrollment target is 68 participants. The study started on 2021-10-18. Estimated completion is 2023-10-20.

What interventions are being tested in trial NCT04925791?

The interventions under investigation include: standardized pre-conditioning treatment (DIAGNOSTIC_TEST), Partial occlusion (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT04925791?

This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04925791's enrollment target sits among peer trials

68 1133rd of 2000 higher than 862 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02044497 · 68 participants · Phase 4

    Population Pharmacokinetics and Pharmacogenomics of Oral Oxycodone in Pediatric Surgical Patients

  • NCT03779854 · 68 participants · Phase 2

    Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant

  • NCT03821246 · 68 participants · Phase 2

    Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy

  • NCT04115514 · 68 participants · Phase 2

    Treatment of ARDS With Instilled T3

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04925791, the US trial registry maintained by the National Library of Medicine. NCT04925791 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.